Silexion Therapeutics faces Nasdaq delisting notice over minimum shareholders’ equity shortfall

Reuters2026/08/21 20:21

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Nasdaq issued a delisting notice on Aug. 18, 2026 over non-compliance with the $2.5 million minimum shareholders’ equity rule.
Shareholders’ equity was $44,000 in the quarterly report for the period ended June 30, 2026.
An appeal to a Nasdaq Hearings Panel is due by Aug. 25, 2026; the company plans to file.
Failure to win the appeal could trigger a trading suspension for ordinary shares and warrants, followed by removal from Nasdaq.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silexion Therapeutics Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178913-26-004223), on August 21, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Silexion Therapeutics faces Nasdaq delisting notice over minimum shareholders’ equity shortfall

You may also like

Crypto prices